Vol 31 - N° 1 - février 2005
P. 7-95© Elsevier Masson
Page :7-13
H Gin, H Hanaire-Broutin
Page :15-22
DN Kiortsis, TD Filippatos, MS Elisaf
Page :23-27
A Fredenrich, PA Grimaldi
Page :29-34
D Bataille
Page :35-39
G Prevost, I Fajardy, C Besmond, B Balkau, J Tichet, P Fontaine, PM Danze, M Marre, the Genediab and D.E.S.I.R studies
Page :41-46
M Lièvre, JJ Robert, G Charpentier, F Iannascoli, P Passa, on behalf of the DIabetes, therapeutic Strategies and COmplications (DISCO) investigators
Page :47-54
E Cosson, AF Bringuier, J Paries, R Guillot, J Vaysse, JR Attali, G Feldmann, P Valensi
Page :55-62
M Valle, R Martos, F Gascón, R Cañete, MA Zafra, R Morales
Page :63-68
WY Chien, KD Yang, HL Eng, YH Hu, PY Lee, ST Wang, PW Wang
Page :69-77
F Maillot, MA Garrigue, M Pinault, M Objois, V Théret, F Lamisse, C Hoinard, JM Antoine, D Lairon, C Couet
Page :78-82
MR Ababou, M Ababou, A El Maliki
Page :83-86
R Bouguerra, L Ben Salem, H Chaâbouni, L Laadhar, O Essais, M Zitouni, S Haouet, C Ben Slama, A Ben Ammar, B Zouari, S Makni
Page :87-89
P Schaepelynck-Bélicar, L Dufaitre-Patouraux, V Lassmann-Vague
Page :90-95
O Ronsin, MF Jannot-Lamotte, P Vague, V Lassman-Vague